Loading
BI
Baxalta Inc Stock: price and insider trades · United States
Baxalta Inc: what insiders have been doing
We have very little insider data for Baxalta Inc so far: the most recent filing dates from 2 February 2016. With so few records, no pattern can be drawn yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2015FY ended December 2015 · cache
Income statement
RevenueUS$5.3B
Gross profitUS$3.3B61% margin
Net incomeUS$827.6M15.5% margin
Last declaration on 2 February 2016
Declarations1 total
37,573,040 sharesCommon Stock, par value $0.01 per shareSEC:0000899243-16-012534:0
1 of 1 declaration
About Baxalta Inc
Baxalta Inc is a biopharmaceutical company focused on developing treatments for hematologic and immunologic diseases. It was founded in 2015 and is listed on NASDAQ under the symbol BXLT.
